6CQQ | date | ![]() |
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||||||
compound | source | ||||||||||||||||||
symmetry |
| ||||||||||||||||||
crystal cell |
| ||||||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||||||
ligand | EDO, MG, NAG, SO4 | enzyme |
| ||||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||||||
Primary reference | CD4(+) T cell-mediated HLA class II cross-restriction in HIV controllers., Galperin M, Farenc C, Mukhopadhyay M, Jayasinghe D, Decroos A, Benati D, Tan LL, Ciacchi L, Reid HH, Rossjohn J, Chakrabarti LA, Gras S, Sci Immunol. 2018 Jun 8;3(24). pii: 3/24/eaat0687. doi:, 10.1126/sciimmunol.aat0687. PMID:29884618 |
Data retrieval |
![]() |
View 6CQQ in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |